⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
NVS News
Novartis AG
Brandon Capital Announces Agreement for Novartis to Acquire Portfolio Company Myricx Bio to Advance New Class of Cancer Therapeutics
globenewswire.com
NVS
LLY
Myricx Bio to be Acquired by Novartis to Advance Next-Generation ADC Payloads for Oncology with Novel NMTi Platform
globenewswire.com
LLY
NVS
Novartis agrees to acquire Myricx Bio, advancing next-generation antibody-drug conjugate innovation with a novel NMTi payload, expanding options for cancer patients
globenewswire.com
NVS
Tumor Microenvironment Modulation Market to Hit USD 3.73 Billion by 2031 with a 7.4% CAGR - Key Trends and Insights
globenewswire.com
BMY
MRK
AZN
PFE
REGN
GILD
AMGN
BE
LLY
IOVA
NVS
Global Cancer Biologics Market Poised to Reach USD 189 Billion by 2035 with a CAGR of 8.9%
globenewswire.com
ABT
ABBV
AMGN
AZN
BNTX
BMY
LLY
GILD
JNJ
MRK
NVS
PFE
SNY
TAK
Sky Labs Showcases 'CART BP pro' for Potential Use in Drug Clinical Trials on Global Stage
prnewswire.com
NVS
Sky Labs Showcases 'CART BP pro' for Potential Use in Drug Clinical Trials on Global Stage
prnewswire.com
NVS
Non-Small Cell Lung Cancer Market Poised for Robust Expansion at a 6.6% CAGR Through 2036, Driven by Emerging Targeted and Immunotherapy Innovations | DelveInsight
prnewswire.com
PFE
ABBV
RMD
GSK
AZN
BNTX
INCY
IOVA
RGEN
MRK
LLY
IBIO
GILD
AMGN
JNJ
NVS
RIGL
BIIB
Novartis receives European Commission approval for Itvisma® for spinal muscular atrophy (SMA)
globenewswire.com
NVS
Global Smart Inhalers Market to Witness Robust CAGR Growth Through 2030, Driven by Technological Innovation and Digital Health
globenewswire.com
AZN
NVS
GSK